Fair-Value Report — Omnibridge Holdings Ltd. (8462)

Insider Signal

Verified Snapshot

Price, range and market cap: stockanalysis.com, investing.com, Google Finance (all cross-checked, as of 1 Sep 2026). Balance-sheet figures below: stockanalysis.com / TipRanks financial data (aggregated from the company's HKEX filings); reported in SGD, converted at SGD/HKD ≈ 6.16 (31 Aug 2026). The primary HKEXnews interim-results PDF could not be retrieved directly during this review (repeated fetch attempts returned mismatched documents for unrelated issuers) — figures below rely on two independent aggregators that agree closely with each other.

Business & Recent Performance

Omnibridge is a small Singapore/Hong Kong staffing outsourcing and recruitment business (secondment of outsourced staff plus permanent-placement recruitment), listed on GEM since 2017. It is a people-business with essentially no capital intensity — no goodwill or intangibles on the balance sheet, minimal debt.

Revenue has nearly halved since its FY2022 peak, and FY2025 gross profit swung negative (~-S$0.30M, vs +S$4.13M in FY2024) — cost of outsourced staff now exceeds what the company bills clients for it. Net income for FY2025 was essentially breakeven (S$18k), and the six months to 30 June 2026 reportedly ran a small net loss (~-S$0.28M) despite a partial revenue recovery, per aggregator data. This is a genuinely weakening core operating trend, not a data artifact.

Balance sheet (31 Dec 2025 / 30 Jun 2026): total equity S$23.5M / S$23.2M, of which cash alone is S$20.1M / S$19.7M — ~85% of book value is cash, receivables ~S$4.6–4.9M, total debt only S$0.1–0.3M. No dividend has ever been paid, and there is no evidence of a placing, rights issue or share consolidation — the 600M share count has been stable since IPO, so the price decline is organic, not dilution-driven.

Valuation — Asset (P/B) + Optionality

With FY2025 gross margin negative and H1-2026 back in a small net loss, this is a marginal/loss-adjacent operating business — a DCF on unreliable, shrinking cash flows would manufacture false precision. The right lens is asset value: the company's book is overwhelmingly cash, and the market is pricing the whole enterprise (business + cash) at a steep discount to that cash alone.

Peer table (micro-cap HK staffing/HR peers, similar size)

Both peers are also thin/negative-margin GEM-board staffing businesses (KOS: near-breakeven; ETS: net loss), yet both trade near or above book. Larger, profitable HR-services names for context only (not size-comparable): Renrui HR Tech (6919, P/E 10.9x), ManpowerGroup Greater China (2180, P/E 7.2x), Tongdao Liepin (6100, P/E 12.5x). Peer median P/B (8042/8031) ≈ 1.3x — Omnibridge trades at a ~77% discount to that median.

Scenario table

Reverse read

At HK$0.071, the market is pricing Omnibridge below its own net cash — i.e., assigning a negative value to the operating business and assuming minority shareholders will never see the cash (no dividend history, controlling family now past 50%, thin free float, GEM-board neglect). That is a harsh but not irrational prior given the negative FY2025 gross margin and H1-2026 loss. The insider buying is the one concrete data point pushing against that prior: the chairman and his spouse are adding shares — modestly, in absolute dollar terms (~HK$1.0M combined across both tranches, small next to their existing ~$290M-share stake) — but at prices that, on the numbers above, were already well inside a wide margin of safety.

Conclusion

Signal real, price statistically cheap, business weak. This is not a story of a hidden turnaround — the core HR-outsourcing franchise is shrinking and briefly ran a negative gross margin. But the founder/CEO and his spouse, who already control the company, are buying on-market at prices representing a fraction of book and even of net cash, and the balance sheet backs that margin of safety with real, low-risk assets (mostly cash, minimal debt, no goodwill). The combination of genuine insider buying + an extreme, peer-relative valuation discount supports a Speculative Buy — sized small, for patient capital willing to underwrite GEM-board illiquidity and the absence of a clear near-term catalyst to close the discount.

Key Risks

• Late DI filings by the chairman (2–3 months late) — a governance flag on disclosure discipline.
• Deteriorating core business: revenue down ~54% from its FY2022 peak; FY2025 gross margin went negative; H1-2026 posted a net loss.
• No dividend policy and no buyback: there is no established mechanism for minority shareholders to realize the net-cash discount; it may simply persist indefinitely.
• Related-party/control risk: the founding family now controls >50% of the register with only three independent non-executive directors as a check — any related-party use of the cash pile would be a red flag to monitor going forward (none identified in this review).
• GEM-board illiquidity and thin coverage: the primary HKEXnews interim results PDF could not be independently retrieved during this review; figures rely on two cross-checked third-party aggregators rather than the raw filing.
• Small insider commitment: ~HK$1.0M of combined buying is modest next to the founders' existing stake — a supportive signal, not a transformative one.
• FX: the business reports in SGD; HKD share price is translated at SGD/HKD ≈ 6.16 (31 Aug 2026), so results are also subject to SGD/HKD movements.

Sources

• HKEX Disclosure of Interests filings (DA20260831E00228/00230/00237/00239), captured via local DI scanner
• stockanalysis.com — Omnibridge (8462), KOS International (8042), ETS Group (8031): price, income statement, balance sheet
• TipRanks — Omnibridge (8462) income statement / balance sheet cross-check
• Investing.com, Google Finance — current price, 52-week range, market cap (1 Sep 2026)
• omnibridge.com.hk — investor relations / company description
• Web search aggregation — company profile, director/shareholding structure, peer identification